Sponsor Pipeline

Biohaven Therapeutics Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
13
Active Trials
7
Recruiting
5
Phase 3
3
Disease Areas
2
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-06 NCT07661056
Study to Determine if BHV-1300 is Effective and Safe in Adults With Graves' Disease
Trial sites expanded: 24 -> 28 locations
2026-07-21 NCT07661056
Study to Determine if BHV-1300 is Effective and Safe in Adults With Graves' Disease
Trial sites expanded: 15 -> 20 locations
Active Trials by Phase
Phase 3
2
Phase 2/3
3
Phase 2
2
Phase 1/2
1
Phase 1
4
Not specified
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07661056 Study to Determine if BHV-1300 is Effective and Safe in Adults With Graves' Disease Graves Disease Recruiting
NCT07642050 A Study to Determine if BHV-1400 is Effective and Safe in Adults With IgA Nephropathy IgA Nephropathy Not Yet Recruiting
Phase 2/3
NCT06132893 A Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal… Focal Epilepsy Recruiting
NCT06976268 A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for… Parkinson Disease Recruiting
NCT06309966 Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal… Focal Epilepsy Active, Not Recruiting
Phase 2
NCT07281495 Taldefgrobep Alfa in Adults With Overweight and Obesity Obesity Active, Not Recruiting
NCT06443463 Long-term Safety and Tolerability of BHV-7000 Focal Epilepsy Enrolling by Invitation
Phase 1/2
NCT06384807 A Phase 1/2 Study of BHV-1510 (Previously PBI-410) in Advanced Solid Tumors Solid Tumor Recruiting
Phase 1
NCT07054684 Study of BHV-1400 in IgA Nephropathy IgA Nephropathy Recruiting
NCT06874335 A Phase 1 Study of BHV-1530 in Advanced Solid Tumors Solid Tumor Recruiting
NCT06980649 Study of BHV-1300 in Graves' Disease Graves Disease Recruiting
NCT07262268 A Phase 1b Study of BHV-7000 in Participants With Inherited Erythromelalgia Familial Erythromelalgia Enrolling by Invitation
Not specified
NCT06529146 Real-World Data Study of Troriluzole-Treated Patients With Spinocerebellar Ataxia (SCA)… Spinocerebellar Ataxias Active, Not Recruiting
Disease Areas
Get alerts when Biohaven Therapeutics Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free